## STT: State Street Corporation - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.05 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: overbought RSI (72).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($121.22)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. State Street Corp Sells 1,675,911 Shares of Citigroup Inc. $C**
- Source: MarketBeat | 20251209T130842 | Neutral | Relevance: 98%
- State Street Corp reduced its stake in Citigroup Inc. by 2.0% in the second quarter, selling 1,675,911 shares, yet still maintaining 82,106,479 shares valued at approximately $6.99 billion. Analysts have a "Moderate Buy" consensus rating for Citigroup, with an average target price of $108.70, and several firms recently raised their price targets. Citigroup reported strong quarterly earnings, beating estimates with $2.24 EPS on $22.09 billion revenue, and also declared a quarterly dividend of $0.60 per share.

**2. State Street Corp Sells 480,944 Shares of Mastercard Incorporated $MA**
- Source: MarketBeat | 20251209T130839 | Neutral | Relevance: 92%
- State Street Corp reduced its stake in Mastercard Incorporated by 1.3% during the second quarter, selling 480,944 shares. Despite this reduction, Mastercard remains State Street's 18th largest position, valued at approximately $19.995 billion. Other institutions like Norges Bank and Wellington Management increased their holdings, contributing to institutional investors owning 97.28% of Mastercard's stock.

**3. State Street Corp Has $8.37 Billion Position in Accenture PLC $ACN**
- Source: MarketBeat | 20251209T130836 | Somewhat-Bullish | Relevance: 91%
- State Street Corp increased its stake in Accenture PLC to 28,016,605 shares valued at $8.37 billion, marking a 1.2% boost in the second quarter. Institutional investors and hedge funds collectively own 75.14% of Accenture's stock, with notable new positions from Norges Bank. Despite recent analyst price target trims, the consensus for Accenture remains a "Moderate Buy," and the company recently raised its quarterly dividend to $1.63 per share.

**4. State Street Corp Grows Stock Holdings in PepsiCo, Inc. $PEP**
- Source: MarketBeat | 20251209T134700 | Neutral | Relevance: 86%
-  State Street Corp increased its stake in PepsiCo, Inc. by 1.6% in the second quarter, now owning 58,419,849 shares valued at over $7.7 billion. Other institutional investors also adjusted their holdings, and analysts have provided varied ratings and price targets for PepsiCo, with an average "Hold" rating and a target price of $156.90. PepsiCo recently reported quarterly earnings topping estimates and declared a quarterly dividend of $1.4225 per share.

**5. State Street Corp Has $5.24 Billion Holdings in Vertex Pharmaceuticals Incorporated $VRTX**
- Source: MarketBeat | 20251209T131408 | Neutral | Relevance: 85%
-  State Street Corp trimmed its stake in Vertex Pharmaceuticals (VRTX) by 0.1%, holding 11,775,227 shares valued at $5.24 billion. The pharmaceutical company exceeded quarterly expectations with an EPS of $4.80 and revenue of $3.08 billion, despite some insider selling and a slight dip in stock price. Institutional investors own 90.96% of the company, and analysts have a "Moderate Buy" rating with an average target price of $495.53.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 8 ($1.34M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (-0.7%)
- Blackrock Inc.: 8.7% (-1.4%)
- JPMORGAN CHASE & CO: 6.1% (+109.1%)
- State Street Corpora: 4.8% (-2.2%)
- FMR, LLC: 4.0% (+17.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +3.1% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.05 suggests fair value with growth premium. Forward P/E 11.1x attractive for 12% earnings growth. Quality metrics strong (margin 22%). Balance sheet: strong liquidity (8.0x), $7.7B free cash flow. Insider selling cluster ($1.3M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $35.8B |
| Beta | 1.45 |
| 52W Range | $72.81 - $127.07 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.05 |
| Forward P/E | 11.1 |
| Current P/E | 12.4 |
| YoY Growth | 11.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 1.4% to 4.4% (+3.1% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 82nd percentile. MRS_5 at 2.1% confirms short-term momentum alignment. AM_20 at 6.7% shows strong absolute momentum above own 20MA. Outperforming sector by 5.5pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.97), confirming momentum. RSI overbought at 72, risk of mean reversion. Elevated volume (1.4x 20MA), institutional activity likely.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 4.44% (CS: 83) | Strong |
| RSI_14 | 72.2 | Overbought |
| MACD Histogram | 0.97 | Bullish |
| vs SMA20 | 1.067x | Above |
| vs SMA50 | 1.081x | Above |
| vs SMA200 | 1.209x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $126.16
- **Stop Loss:** $121.22 (3.9% risk)
- **Target:** $136.04 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 101
- **Position Value:** $12,742.16
- **Portfolio %:** 12.74%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-15 (Est: $2.81)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.65 | $2.78 | +5.0% |
| 2025Q2 | $2.36 | $2.53 | +7.1% |
| 2025Q1 | $2.01 | $2.04 | +1.7% |
| 2024Q4 | $2.44 | $2.60 | +6.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*